Table: Modalis Therapeutics - 6-MTH group results

Modalis Therapeutics

14/08/2026 01:00

    Aug 14 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Dec 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Operating     loss 989 mln          loss 1.03                   
  Recurring     loss 954 mln          loss 1.02                   
  Net           loss 909 mln          loss 1.02                   
  EPS           loss 9.85 yen      loss 13.78 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T